Moon Surgical’s two-armed Maestro system is designed for minimally invasive laparoscopic procedures. [Photo courtesy of Moon Surgical]
Moon Surgical
Moon Surgical (previously known as MastOR) raised $31.3 million in June to fund hiring and accelerate development of its Maestro robotic surgery system.
Moon Surgical is one of MassDevice’s surgical robotics companies to watch. Its two-armed Maestro system is intended for use at the bedside to assist a surgeon with minimally invasive laparoscopic procedures.
Headquartered in San Carlos, California and Paris, the company was founded in 2019 by Brice Gayet and Pierre Campredon based on research and technology developed at the ISIR robotics lab at Paris’ Sorbonne University.
Maestro’s minimalist and compact design is meant to make the co-manipulative system fast and easy for surgeons to use.
“Everything is within line of sight, and the essentials are within reach. This delivers situational awareness. … The Moon Surgeon just grabs the instruments and moves them,” CEO Anne Osdoit explained in a post on LinkedIn. “… There is no clutching, foot pedals, or voice control distractions. And our surgeons also get to feel the surgery, the retraction, the cutting, the dissection.”
The Series A funding will advance Moon Surgical’s commercialization efforts, as will the support of two board advisors: Dr. Fred Moll and Dr. Steve Oesterle.
Moll is an Intuitive Surgical co-founder and chief development officer of Johnson & Johnson’s Auris Health. J&J is an investor in Moon Surgical through its strategic venture capital arm, Johnson & Johnson Innovation – JJDC.
Oesterle is a former Medtronic SVP and venture partner at Cathay Health, which has also invested in Moon Surgical.
Learn more about Moon Surgical in this June 2022 DeviceTalks interview with Osdoit and Oesterle.
